New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- Flöjelbergsgatan 8C
- Mölndal , SE-431 37
Cellectricon AB headquartered in Gothenburg, Sweden, is a leading life sciences solutions provider of advanced cell based screening products to accelerate drug discovery. The company’s products include the industry leading platforms for high resolution ion-channel screening, and cell engineering.